Intra-Cellular Therapies, Inc. (ITCI) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 8.61B |
| Enterprise Value | 8.32B |
| P/E Ratio | -182.12 |
| PEG Ratio | -0.91 |
| Price/Sales Ratio | 20.63 |
| Price/Book Ratio | 11.84 |
| Enterprise/Revenue | 20.21 |
| Enterprise/EBITDA | -117.86 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | December 31, 2024 |
| Profit Margin | -0.11 |
| Operating Margin | -0.17 |
| Return On Assets | -0.05 |
| Return On Equity | -0.09 |
| Revenue | 680.85M |
| Revenue/Share | 6.6 |
| Gross Profit | 623.89M |
| EBITDA | -116.72M |
| Net Income | -74.68M |
| Diluted EPS | -0.72 |
| Total Cash | 1B |
| Total Cash/Share | 9.71 |
| Total Debt | 16.98M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 6.36 |
| Book Value Per Share | 11.14 |
| 52-Week Change | 87.48 |
| 52-Week High | 131.98 |
| 52-Week Low | 64.09 |
| Moving Average 50 Days | 129.42 |
| Moving Average 200 Days | 92.67 |
| Average Volume | 3.62M |
| Shares Outstanding | 106.52M |
| % Held by Institutions | 100.04 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |